baber/WOPTO huggingface dataset:
Patent FI-920161-A0 (FI)
Inventor: ARABIAN SANDRO
IPC: A47K/
Filed: 1992-01-14
Abstract: Unused towel rolled up in a shell (4) is guided between a roller (38) and a tracer (40) for detecting the towel end and via a transport roller (6a), forms a loop and runs via a transport roller (6b) to a roller (13) guided in slots (14a,b) and intended for receiving used towel. To ascertain whether the loop is being used or not, there is a movement sensor (20) with a bar (22) which is suspended rotatably about a horizontal axis and to which is attached a batten (23) via which the towel (5) is guided. Clamped in the bar (22) is the upper end of a piezoelectric element which at its lower end is clamped between parts connected to a sensor housing (21). Since a distinction can be made between use and non-use, it is possible for released unused towel to be retracted again. Various programs can be selected for operating the towel dispenser, and in particular the loop can be formed from unused and used towel or only from unused towel.
Patent FI-922810-A0 (FI)
Inventor: LECHNER ROBERT
IPC: H04B7/26
Filed: 1992-06-17
Abstract: PCT No. PCT/EP90/02258 Sec. 371 Date Jun. 17, 1992 Sec. 102(e) Date Jun. 17, 1992 PCT Filed Dec. 19, 1990 PCT Pub. No. WO91/10333 PCT Pub. Date Jul. 11, 1991.Cordless network terminating units (CNTn) with a remote power-feeding device are connected via U interfaces (U) to a radio communication network with digital local exchanges (DIV-O). The cordless network terminating unit (CNTn) is associated with mobile sections (MT1-MT80). The cordless network terminating units (CNTn) are connected via digital subscriber line modules (SLMD) and digital subscriber line units (DLU) via a packet switching network (Datex-P) to the data processing system (SP) of a service provider. When a connection is being set up, the authorization of the subscriber is directly checked with a database as "authentication" by the service provider. The data transmission occurs via a composite p channel of the ISDN network. This makes it possible to implement party lines and operate different service networks.
Patent FI-930136-A0 (FI)
Inventor: PERCEBOIS ALAIN
IPC: F16L21/08
Filed: 1993-01-13
Abstract: The locking of this sleeve joint with a radially compressed seal is produced by means of toothed inserts (12) having an inclined rear ramp (27) which presses on the inclined ramp (26) of support inserts (11) provided in the anchoring bead (14) of the seal, which become blocked in the rear part of the anchoring groove (7) of the sleeve (1). Application to ductile cast iron pipelines conveying pressurised fluids. <IMAGE>
Patent FI-933322-A0 (FI)
Inventor: SCHAEFER RAINER
IPC: G01N33/53
Filed: 1993-07-23
Abstract: Method for analysing a component of a medical sample by means of an automatic analyser, in which a reaction of the sample is carried using a reagent system and a physically detectable measured variable X resulting from the reaction of the sample with the reagent system is measured in order to determine at least one measured value R for a specific sample, and in which the at least one measured value R is further processed in a processing step by means of a processing unit in order to determine an analytical result A therefrom. According to the invention, in the processing step use is made of the results of neural network training in which for a plurality of standard samples for which the analytical result A is known in each case at least one measured value or one measurement result derived from a plurality of measured values Ri is applied to the input of a neural network, and the analytical result A or a known auxiliary variable combined with the analytical result is applied to the output of the neural network.
Patent FI-935063-A0 (FI)
Inventor: KAWAMOTO ISAO
IPC: A61K31/397
Filed: 1993-11-16
Abstract: A storage stable form of the pivaloyloxymethyl ester of the carbapenem derivative known as (1R, 5S, 6S)-2-[(4R)-2-oxo-4-pyrrolidinylthio]-6-[(1R)-1-hydroxyethyl]-1-methyl -1-carbapen-2-em-3-carboxylic acid in crystalline form. <IMAGE>
Patent FI-941658-A0 (FI)
Inventor: MOLOCK FRANK
IPC: C08L101/00
Filed: 1994-04-11
Abstract: An ophthalmic lens, particularly a soft hydrogel contact lens, is disclosed. The lens can be derived from a crosslinked polymer made by reacting a hydrophilic monomer with a crosslinking amount of a polyfunctional compound containing a saccharide residue. The preferred hydrophilic monomer is actually a mixture of the following individual hydrophilic monomers: a) the reaction product of a free radical reactive monoisocyanate and a monoalkoxy polyalkylether, b) N,N-dimethylacrylamide, and optionally c)hydroxyethyl methacrylate. The preferred polyfunctional compound is a prepolymer derived from an alkoxylated glucose or sucrose. This prepolymer can be made by reacting glucose or sucrose, which has been ethoxylated or propoxylated, with a free radical reactive isocyanate which has been capped. The free radical reactive isocyanate can be capped by reacting it with a polyalkylether, such as polyethylene glycol, and then reacting this intermediate with a diisocyanate. Advantageously, a fluorinated monomer is added to the reactive components from which the crosslinked polymer of the lens is derived. The preferred fluoromonomer is composed of the reaction product of a free radical reactive monoisocyanate and perfluorooctanol. The polymerization is ideally carried out in the presence of an inert diluent, preferably the boric acid ester of polyethylene glycol 400.
Patent FI-955409-A0 (FI)
Inventor: FOO MAN YIN
IPC: D06F71/34
Filed: 1995-11-09
Abstract: A steam press for pressing fabric wherein a movable upper member (52) is disposed above a stationary lower member (50) and the press has open and closed positions at which the movable upper member (52) is respectively spaced from or engages the lower member (50). Fabric is pressed when disposed between the two engaged members. The upper member (52) includes an inlet water port (56), an electrically energizable element (58) adapted to heat the surface of said upper member (52) adjacent the lower member (50) and when water is delivered to the inlet port (56) to heat said water into steam, and bottom disposed steam outlet ports (62) for discharging steam into the fabric while being pressed. A water reservoir (1) has a water outlet port (17). A pump has a body (9) with an inlet connected to the reservoir outlet and an outlet (18) connected to the water inlet port (56) and also has a piston (16) slidable back and forth in the body. A direct current motor (2) has a drive shaft which rotates in one direction when a direct voltage of selected polarity is applied to the motor (2) and which rotates in opposite direction when the polarity of the applied voltage is reversed. The drive shaft is coupled to the piston (16) to move the piston (16) longitudinally in the pump body (9) in one selected direction to draw water out of the reservoir (1) into the pump body (9) when the shaft rotates in one selected direction and to move the piston (16) longitudinally in the pump body (9) in the other direction to force water out of the pump body (9) into the inlet water port (56) in the upper member (52) when the shaft rotates in the other direction. A direct voltage of one polarity is supplied to the motor to cause water to be drawn out of the reservoir (1) into the pump body (9) and then is supplied with reversed polarity to force water out of the pump body (9) into the inlet water port (56).
Patent FI-960137-A0 (FI)
Inventor: DUPONT MARTINE JEANNE
IPC: C08F2/48
Filed: 1996-01-11
Abstract: UV-curable block copolymer composition comprising: (a) 100 parts by weight of a block copolymer comprising at least one polymer block A derived from a monovinyl aromatic compound and at least one polymer block B derived from a conjugated diene, wherein: the content of monovinyl aromatic compound is in the range of from 5 to 50 % by weight based on the total weight of block copolymer; each block A has an apparent molecular weight in the range of from 1,000 to 50,000; and each block B has an apparent molecular weight in the range of from 10,000 to 250,000; and (b) 0.5-30 parts by weight of at least one photoinitiator, characterized in that the block copolymer is a multi-armed block copolymer and at least one photoinitiator is used containing a carbonyl group which is directly bonded to at least one aromatic ring structure.
Patent FI-961212-A0 (FI)
Inventor: KOCHS KARL-JOSEF
IPC: A41H37/00
Filed: 1996-03-15
Abstract: PCT No. PCT/EP94/02962 Sec. 371 Date Mar. 18, 1996 Sec. 102(e) Date Mar. 18, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/08278 PCT Pub. Date Mar. 30, 1995A machine for the attachment of buttons, rivets or the like, preferably to articles of clothing, which buttons, rivets or the like consist of an upper portion and a lower portion, a material held between an upper clamping jaw and a lower clamping jaw being punched by actuation of a ram, and, after movement of a slide having an upper tool and a lower tool, the button portions disposed therein being positively connected to one another by ram actuation by virtue of the upper and lower tools being brought towards one another. In order to be able to carry out the punching of the article of clothing which is necessary before the attachment of the object, using the same machine and without changing the position of the article of clothing, an attachment tool (36) at the end of the ram is disposed, in the hole punching disposition (FIG. 3), in coaxial alignment with a hole punching tool (26).
Patent FI-971311-A0 (FI)
Inventor: LIANG SHAOWO
IPC: C07C67/08
Filed: 1997-03-27
Abstract: The present invention provides a process for the preparation of cyclopropanecarboxamide which comprises the steps of:   (1) contacting cyclopropanecarboxylic acid with ammonia in a reactor at a temperature of 200 to 260 DEG C and a pressure of 10 to 100 bar absolute in the absence of both a catalyst and a solvent to form a melt of cyclopropanecarboxamide; (2) venting the reactor at a temperature above the melting point of cyclopropanecarboxamide to reduce the pressure to atmospheric pressure and remove excess ammonia and water of reaction from the cyclopropanecarboxamide; and (3) obtaining from the reactor cyclopropanecarboxamide essentially free of water and ammonia.
Patent IL-86136-A0 (IL)
Title: Thiadiazole guanidines,process for preparation thereof and pharmaceutical compositions containing the same
IPC: C07D285/12
Filed: 1988-04-20
Abstract: Thiadiazole guanidines of formula 1 <CHEM>  wherein R is hydrogen or C1-4 alkyl and their non-toxic salts. Processes for their preparation and pharmaceutical compositions thereof. The compounds exhibit anti-convulsant activity and are indicated for use in the treatment of epilepsy.
Patent IL-91959-A0 (IL)
Title: Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-1-methoxy carbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
IPC: C07D405/06
Filed: 1989-10-12
Abstract: Cis  alpha  alpha / beta  beta -3-amino-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one is resolved via optically active malic acid.
Patent IL-97195-A0 (IL)
Title: Imidazole compounds,processes for their preparation,pharmaceuticals based on these compounds and some intermediates
IPC: C07D401/12
Filed: 1991-02-08
Abstract: Imidazole derivs. of formula (I) and their salts are new. R1 = 1-6C alkyl. R2, R3 = independently H, F, Cl, Br, I or 1-3C alkyl. X = OH or -NR4R5. R4 = H or 1-7(1-4)C alkyl, opt. substd. by CN, NH2 or CO2H. R5 = 1-8 (1-5)C alkyl, opt. interrupted by phenyl and opt. substd. by not less than 1 OH, 1-3C alkoxy, (un)substd. phenyl, CO2H, CO2-(1-3C alkyl), -CONH2, CN, 2-5C alkynyl, NH2, NHR6, N(R6)2, N+(R6)3, NH-CO-(1-6C alkyl), a gp. of formula (i), a monocyclic 5-7 membered (un)saturated opt. substd. heterocycle with one N heteroatom, and opt. an extra N, O or S heteroatom, where the S atom can be oxidised to SO or SO2. Alternatively, R4 and R5 together form a 5-7 membered opt. substd. heterocycle which may contain, in addn. to the amide N atom, a further N, O or S heteroatom. The heterocycle is not morpholine. R6 = independently 1-4C alkyl, 2-6C alkoxyalkyl or phenyl-(1-3C alkyl). N-(2-morpholinoethyl)-1-methyl -2-imidazolsulphonic acid amide and N-(2-morpholinopropyl) -1-methyl-4-imidazolsulphonic acid amide are specifically claimed. Also claimed.are methods for preparing (I), e.g. by sulphonation of the corresponding mono-, di- or trisubstituted imidazole cpd.
Patent IL-98715-A0 (IL)
Title: Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
IPC: A61K39/10
Filed: 1991-07-02
Abstract: This invention pertains to immunogenic conjugates comprising an antigen bound to a filamentous hemagglutinin of Bordetella pertussis and a method of eliciting an immune response against an antigen comprising administering such an immunogenic conjugate with a pharmaceutically acceptable vehicle to a vertebrate host.
Patent IL-99222-A0 (IL)
Title: Monoclonal antibodies to leptosphaeria
IPC: C12N5/10
Filed: 1991-08-19
Abstract: The invention relates to monoclonal antibodies that react specifically with members of the genus Leptosphaeria and hybridomas that produce such antibodies. The invention is further directed to a method for making a hybridoma cell line that produces monoclonal antibodies that react specifically with at least one species of Leptosphaeria, and a method of obtaining monoclonal antibodies therefrom. Methods and kits for diagnosing Leptosphaeria infections in plant material using such monoclonal antibodies are also within the scope of the invention.
Patent AU-PR703601-A0 (AU)
Title: Identification and isolation of somatic stem cells and uses thereof
IPC: A61K35/36
Filed: 2001-08-15
Abstract: The present invention relates to the identification of a specific population of cell types, in particular somatic stem cells including haematopoietic stem cells, mesenchymal stem cells and keratinocyte stem cells. The invention also provides for methods of isolation and uses of the stem cells. Derived from the methods of the present invention, there is provided a method of identifying a stem cell comprising the steps of: obtaining a cell sample including stem cells; detecting the presence of angiotensin converting enzyme (ACE) or a fragment thereof on a cell; and identifying the stem cells having ACE or a fragment thereof.
Patent FI-20011787-A0 (FI)
Inventor: SUNDHOLM GOERAN
IPC: F02C3/30
Filed: 2001-09-10
Abstract: A method for producing a mist in a spray head ( 1 ), especially for fire-fighting purposes or for humidification of intake air, in which method a medium, preferably an extinguishing medium, is supplied under pressure into the chamber ( 2 ) of the spray head via an inlet ( 3 ) and through at least one first channel ( 4 ) into at least one nozzle ( 5 ), which comprises at least one channel zone ( 6 ) narrower in a direction transverse to the flow of medium and after that in the direction of flow of medium a channel space ( 7 ) wider in a direction transverse to the flow of medium than the narrow channel zone, from which wider channel space the mist of medium generated is passed out of the spray head via an outlet orifice ( 8 ). The mist of medium is influenced, at least by increasing its momentum and/or reducing its droplet size, by supplying into the channel space ( 7 ) at least one second medium, preferably a gas.
Patent FI-20115863-A0 (FI)
Inventor: KAINUMAA SAKARI
IPC: B32B/
Filed: 2011-09-02
Abstract: Composite panel (1) and method for manufacturing it, as well as a composite-panel combination. The composite panel contains at least two wood-based panels (10, 20) and an insulation layer (30) fitted between them. According to the invention, the insulation layers (40, 50) are fitted on both sides of the wood-based panels (10, 20)), and the said wood-based panels and insulation layers are attached to each other by gluing, with the aid of a single pressing.
Patent IL-106164-A0 (IL)
Title: Polyazamacrocyclic compounds and their complexes with metal ions
IPC: A61K51/04
Filed: 1993-06-29
Abstract: A nuclear magnetic resonance contrast composition which comprises a tetraazamacrocyclic compound - paramagnetic lanthanide complex having the formula: <CHEM>     where     x is 2, 3 or a combination of p 2(s) and   q 3(s) where p + q = 4;   R is (CH2)zP(=O)OR<1>OR<2>;   R<1> is H or CH3;   R<2> is CnH1+2n;   z is 1 to 3;   r is 2 or 3;   M is a paramagnetic lanthanide; and   n is 4 to 6.   The nuclear magnetic resonance contrast compositions are particularly suitable for liver imaging in a subject.
Patent IL-107614-A0 (IL)
Title: Vitamin d3 analogs their preparation and pharmaceutical compositions containing them
IPC: A61K31/593
Filed: 1993-11-15
Abstract: Compounds of the formula <CHEM> wherein R<1> and R<2> are hydrogen or acyl; provided that only one of R<1> or R<2> is hydrogen, useful in the treatment of hyperproliferative skin diseases and sebaceous gland diseases.
Patent IL-122153-A0 (IL)
Title: Biocompatible polymeric coating material
IPC: A61L27/34
Filed: 1997-11-10
Abstract: The invention provides a biocompatible polymeric coating material selected from the group consisting of linear, dendrimeric and branched polymers which contain primary, secondary, tertiary or quaternary amine groups with hydrophobic side chains and which polymers are insoluble, or only slightly soluble, in aqueous solution at a pH range between 3 and 11 and soluble in at least one organic solvent selected from the group consisting of alcohols, acetone, methyl ethyl ketone, tetrahydrofuran, dioxane, chloroform, dichloromethane, hexanes, mixtures thereof and mixtures of any of the above with water. The invention also provides the use of such a polymeric material in a biocompatible coating composition; a biocompatible coating composition including such a polymeric material; and a coated product including a substrate to which such a coating composition has been applied. The substrate may be, for example, a cell growth culture substrate or a medical device.
Patent IL-127923-A0 (IL)
Title: Oral contraceptive
IPC: A61P15/18
Filed: 1997-07-23
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4mg dienogest, or 250  mu g - 4mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 3-8 days beginning on day 1 of the menstrual cycle, wherein the same dosage of the progestin and estrogen combination is administered in each of the 3-8 days, a second phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 4-15 days, beginning on the day immediately following the last day of administration of the first phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days, and a third phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 4-15 days beginning on the day immediately following the last day of administration of the second phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days provided that the daily dosage of the combination administered in the first phase is not the same as the daily dosage of the combination administered in the second phase and that the daily dosage of the combination administered in the second phase is not the same as the daily dosage of the combination administered in the third phase.
Patent IL-127995-A0 (IL)
Title: Raised mounting system for artistic work
IPC: B44C5/02
Filed: 1997-06-30
Abstract: A framed art reproduction comprises: i) a thin sheet of deformable substrate having an artistic image reproduced on a front face thereof, ii) the thin sheet having an integral raised land portion containing the image, an integral flange surrounding the raised land and an integral continuous lip interconnecting the raised land to the flange, the lip being of a predetermined height defined by an extent to which the raised land is deformed in the substrate; iii) a matte for framing the raised land, the matte having an aperture provided therein as defined by an aperture edge of the matte, the aperture edge being dimensioned to engage the continuous lip and locate thereby the raised land relative to the matte; and iv) means for securing the located raised land in the matte with the flange contacting the matte.
Patent IL-130338-A0 (IL)
Title: Pyrroles as sPLA2 inhibitors
IPC: A61P27/16
Filed: 1997-12-09
Abstract: A class of novel pyrroles is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
Patent IL-133305-A0 (IL)
Title: Use of a cd40:cd154 binding interruptor for treating protein inhibitor syndrome
IPC: A61K39/395
Filed: 1998-06-19
Abstract: Methods and compositions for attenuating or mitigating; suppressing; preventing; delaying onset of; or, reversing exogenous protein inhibitor syndromes, exemplified by clotting factor (e.g., Factor VIII) inhibitor syndromes. The described methods use a CD40:CD154 binding interrupter, such as a CD154 blocking agent, to attenuate or ameliorate counter-adaptive, bioinhibitory humoral immunity directed against an exogenous protein of therapeutic value.
Patent IL-145703-A0 (IL)
Title: Water-soluble compositions of bioactive lipophilic compounds
IPC: A61K31/085
Filed: 2000-02-03
Abstract: A solubilizing agent of the formula  
 X-OOC-(CH 2 ) n -COO-Y  
wherein X is a member selected from campesterol, sitosterol, ergosterol and stigmasterol; 
Y is a member selected from polyalcohol, polyether, polyanion, polycation, polyphosphoric acid, polyamine, polysaccharide, polyhydroxy compound and polylysine, and derivatives thereof; and 
n is an integer selected from 0 to 18.  The solubilizing agent may be included in a water-soluble composition comprising a bioactive lipophilic compound and the solubilizing agent.
Patent IL-146616-A0 (IL)
Title: Method and system for delivery of electronic mail
IPC: B41J5/30
Filed: 2000-05-24
Abstract: A system for capturing an electronic message is disclosed. The system includes a printer, a sensing device and a computer system. The printer prints on a substrate user information visible to a user and coded tags invisible to the user. Each coded tag encodes an identity unique to the substrate and a location of the coded tag on the substrate. The user information defines a message area on the substrate. The sensing device senses the coded tags on the substrate when the sensing device is moved relative to the substrate. The computer system electronically captures a message composed with the sensing device via movement of the sensing device relative to the message area, the computer system using the identity of the substrate and a sequence of respective locations of coded tags sensed by the sensing device for determining the movement relative to the message area and the message.